Department of Rehabilitation Medicine, Ruijin Hospital, School of Medicine, Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200025, China.
Department of Neurology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Theranostics. 2022 Apr 24;12(7):3553-3573. doi: 10.7150/thno.68895. eCollection 2022.
White matter repair is critical for the cognitive and neurological functional recovery after ischemic stroke. M2 microglia are well-documented to enhance remyelination and their extracellular vesicles (EVs) mediate cellular function after brain injury. However, whether M2 microglia-derived EVs could promote white matter repair after cerebral ischemia and its underlying mechanism are largely unknown. EVs were isolated from IL-4 treated microglia (M2-EVs) and untreated microglia (M0-EVs). Adult ICR mice subjected to 90-minute transient middle cerebral artery occlusion received intravenous EVs treatment for seven consecutive days. Brain atrophy volume, neurobehavioral tests were examined within 28 days following ischemia. Immunohistochemistry, myelin transmission electron microscope and compound action potential measurement were performed to assess white matter structural remodeling, functional repair and oligodendrogenesis. The effects of M2-EVs on oligodendrocyte precursor cells (OPCs) were also examined . EVs' miRNA sequencing, specific miR-23a-5p knockdown in M2-EVs and luciferase reporter assay were used to explore the underlying mechanism. M2-EVs reduced brain atrophy volume, promoted functional recovery, oligodendrogenesis and white matter repair , increased OPC proliferation, survival and differentiation . miR-23a-5p was enriched in M2-EVs and could promote OPC proliferation, survival and maturation, while knocking down miR-23a-5p in M2-EVs reversed the beneficial effects of M2-EVs both and . Luciferase reporter assay showed that miR-23a-5p directly targeted Olig3. Our results demonstrated that M2 microglia could communicate to OPCs through M2-EVs and promote white matter repair via miR-23a-5p possibly by directly targeting Olig3 after ischemic stroke, suggesting M2-EVs is a novel and promising therapeutic strategy for white matter repair in stroke and demyelinating disease.
白质修复对于缺血性中风后的认知和神经功能恢复至关重要。M2 小胶质细胞被广泛证明可以增强髓鞘再生,其细胞外囊泡(EVs)在脑损伤后介导细胞功能。然而,M2 小胶质细胞衍生的 EV 是否可以促进脑缺血后的白质修复及其潜在机制在很大程度上尚不清楚。
从 IL-4 处理的小胶质细胞(M2-EVs)和未处理的小胶质细胞(M0-EVs)中分离出 EVs。将成年 ICR 小鼠进行 90 分钟短暂性大脑中动脉闭塞,然后接受静脉内 EV 治疗 7 天。在缺血后 28 天内进行脑萎缩体积、神经行为测试。进行免疫组织化学、髓鞘透射电镜和复合动作电位测量,以评估白质结构重塑、功能修复和少突胶质细胞发生。还检查了 M2-EVs 对少突胶质前体细胞(OPCs)的影响。使用 EVs 的 miRNA 测序、M2-EVs 中特定的 miR-23a-5p 敲低和荧光素酶报告基因测定来探索潜在机制。
M2-EVs 减少脑萎缩体积、促进功能恢复、少突胶质细胞发生和白质修复、增加 OPC 增殖、存活和分化。miR-23a-5p 在 M2-EVs 中富集,并可促进 OPC 增殖、存活和成熟,而在 M2-EVs 中敲低 miR-23a-5p 则逆转了 M2-EVs 的有益作用。荧光素酶报告基因测定表明,miR-23a-5p 可直接靶向 Olig3。
我们的结果表明,M2 小胶质细胞可以通过 M2-EVs 与 OPC 进行通讯,并通过 miR-23a-5p 促进白质修复,可能通过直接靶向 Olig3 来促进白质修复。这提示 M2-EVs 是中风和脱髓鞘疾病中白质修复的一种新的有前途的治疗策略。